ALB and neoplasm: In the case of the ruthenium complex NAMI-A, support to the role of NO scavenging for its innovative anti-tumour properties is given by the study of Das and Mondal [32] who have stressed the capacity of the adduct of NAMI-A with serum albumin to efficiently bind the nitrosyls, then immediately to undergo reduction to the more reactive ruthenium(II), a phenomenon that in the mind of these authors would explain the anti-metastatic properties of this drug.